Thank you for your interest in the iHope Genetic Health (iGH) program. Our initiative donates clinical genome or exome sequencing tests to selected clinical partner sites, aiming to provide crucial answers for underserved families with children suspected of having rare, undiagnosed genetic diseases.
The primary goal of this testing is to furnish physicians with valuable information to aid in the diagnosis of inherited diseases and to potentially identify the underlying causes of genetic conditions. By expanding our program to additional clinical sites, particularly in low- and middle-income countries (LMIC), we hope to extend our reach and impact even further.
Please note that partnership with iGH requires the establishment of a formal contract between the clinical institution and Genetic Alliance. We appreciate your interest in joining our efforts to advance genetic health and support underserved communities.
Kindly complete the following questionnaire to apply for participation in the iGH program.
iHope Site Feasibility Survey